Cancyt 100mg Injection

• As per CDSCO and USFDA, Cancyt 100 mg injection is indicated in the treatment of the following conditions.
• For the remission of acute myeloid leukaemia (type of blood cancer) in adults
• In the treatment of other types of acute leukaemia in adults and children.

• If you have a serious hypersensitive reaction to Cytarabine or other similar anti-cancer medicines. Allergies to this medicine are common. So, hypersensitivity should be checked before giving this injection.
• If you have any history of anaemia (low red blood cells), leucopenia (low white blood cell count), and thrombocytopenia (low platelet count) due to non-cancerous conditions (e.g. bone marrow aplasia).
• If you are diagnosed with chemical arachnoiditis, a syndrome caused mainly by nausea, vomiting, headache and fever. If left untreated, chemical arachnoiditis may be fatal.
• If you are diagnosed with any degenerative and toxic encephalopathies (damage or disease that affects the brain), especially after the use of methotrexate or treatment with ionising radiation.
• If you want to give this medicine intramuscularly (IM) or into the muscle.
• If you have an infusion reaction with symptoms such as low blood pressure, shock, or cardiac arrest.
• If your blood tests show any changes in the total blood count after starting this injection, inform your doctor.

• Nausea
• Vomiting
• Hair loss
• Abdominal pain
• Anal ulcers
• Anaemia (low number of red blood cells)
• Decreased white blood cell count

Other General Warnings

• You have a severe kidney illness.
• You have any symptoms of infection such as fever, fatigue, chills, etc.
• You want to conceive or plan for a pregnancy.
• You have recently taken a live vaccination.
• Your total blood cell count is going down.
• You have high blood uric acid levels.
• You are having breathing difficulties.
• You have watery or bloody diarrhoea.
• You have liver-related issues like jaundice (yellowing of skin and eyes), raised liver function test, etc.
• You notice any central nervous system effects like dizziness, confusion, altered levels of consciousness, epilepsy or movement abnormalities, etc.
• You develop irritation at the site of injection.

• Cancyt injection is given to the patient in the hospital by the doctor or a nurse.
• Do not take this injection by yourself.
• Do not stop using this injection in the middle of the treatment.
• Cancyt injection is given only into a vein or intravenously (IV) or subcutaneously.
• This injection is given as an infusion.
• Follow the instructions given by the doctor during the injection and for aftercare.
• If you are having any breathing problems, rash, swelling, and other side effects, inform your doctor immediately.
• Try not to take Cancyt 100 mg injection on an empty stomach, as it can worsen nausea.

Overdose

Missed a Dose

How Does It Work?

Interactions with other medicines

• Do not use 5-Fluorocytosine, an antifungal medicine, along with Cancyt 100 mg injection. The combination of these medicines has completely abolished the therapeutic effectiveness of 5-fluorocytosine.
• Inform your doctor if you are using Digoxin, a beta-blocker (type of heart medication), while going through treatment with Cancyt 100 mg injection, as the levels of digoxin can fluctuate. Hence, monitoring the dosage of digoxin is required.
• It is better to notify your doctor if you are using gentamicin (an antibiotic) for pneumonia before starting the chemotherapy with Cancyt 100 mg injection. The levels of gentamicin are lower, which can lower the effectiveness and increase infection. In such cases, the antibiotic should be either changed in dose or should be adjusted.
• Following the treatment with this injection, all types of bacterial, viral or fungal infections are common, as this medicine lowers immunity. If you are using any other medicines that lower the immunity, the effect can be additive and increase the immunosuppressive action.

Interactions with food items

• Try to avoid food products that are excess in Folic Acid, such as black-eyed peas, adzuki beans, etc., as it can interfere with the effectiveness of this injection in treating blood cancer.